Skip to main content
. 2009 Feb 16;156(5):807–817. doi: 10.1111/j.1476-5381.2008.00082.x

Table 4.

In viv o effects of treatment with M3 receptor antagonists on bladder intravesical pressure and arterial blood pressure

Compound ED25 (nmol·kg1, i.v.)
IVP inhibition MAP increase
Tolterodine 299.2 820
Darifenacin 53.2 >1000
Solifenacin 200.9 >3000
SVT-40776 17.1 >3000

Values are calculated from n = 4–6 animals per dose. Darifenacin was not given at higher doses because of its solubility problems.

IVP, intravesical pressure; MAP, mean arterial pressure.